Raw Materials CAS 212268-12-7 Favipiravir Pharmaceutical Favipiravir Powder
Product Details
| Product Name |
Favipiravir |
| Apperance |
White Powder |
| CAS |
212268-12-7 |
| MF |
C5h4fn3o2 |
| MW |
157.10 |
History
Favipiravir is a broad-spectrum antiviral drug and was approved by the Medicines Agency of India (DCGI) last week for "emergency restriction" in patients. Granmark will sell the generic drug favipiravir under the brand name FabiFlu. Favipiravir was initially developed by a company in the late 1990s and was later acquired by Fujifilm Corporation of Japan as part of its transformation from the photography business to the healthcare business. After testing a series of viruses, this drug was approved in Japan in 2014 and can be used for the emergency prevention of influenza epidemics or the treatment of new types of influenza.
Application&Function
Research on Antiviral Activity
Studies have shown that, in addition to the influenza virus, favipiravir also demonstrates excellent antiviral activity against a variety of RNA viruses, such as Ebola virus, SARS virus, Bunyavirus, rabies virus, etc. The latest research shows that favipiravir has a certain inhibitory effect on novel coronavirus pneumonia.
Mechanism of action
Favipiravir is a nucleoside antiviral drug, and its mechanism of action has not been fully explained yet. Its target of action is the viral RNA-dependent RNA polymerase. After oral absorption, this drug is converted into the biologically active nucleoside triphosphate of favipiravir, which has a structure similar to purine and can compete with purine for viral RNA polymerase. The nucleoside triphosphate of favipiravir can also be inserted into the viral RNA chain, inducing fatal mutations of the virus. Therefore, mechanically speaking, favipiravir has potential antiviral effects on various RNA viruses.
Application
Favipiravir can be used for antiviral treatment of influenza A and B. Studies have shown that, in addition to influenza virus, this drug also demonstrates good antiviral activity against a variety of RNA viruses, such as Ebola virus, SARS virus, Bunyavirus, rabies virus, etc.
Specification
Audited Supplier 
){kind=link}